NL-OMON53355招募中不适用
Monoclonal antibodies as a treatment for Lassa virus - Counteract
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Written informed consent to store samples and perform genetic testing.
- •- Age >= 18 years
- •- Individuals who have experienced PCR proven LASV infection and minimally 4
- •weeks post-infection
排除标准
- •- Mental disorder that in the view of the investigator would interfere with
- •adherence to the treatment or the study procedures, or the decision to
- •participate in the study.
- •- Immunosuppressive medication or other diseases associated with
- •immunodeficiency.
研究者
相似试验
进行中（未招募）
1 期
Monoclonal antibodies for treatment of bone marrow cancer. multiple myeloma.MedDRA version: 19.1Level: LLTClassification code 10028567Term: Myeloma, malignantSystem Organ Class: 100000004864Multiple MyelomaEUCTR2014-005189-31-DKDept Hematology SLB Vejle60
Unknown
2 期
Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized SettingCovid19NCT04840459Sohail Rao1,000
进行中（未招募）
1 期
Intrathecal therapy with monoclonal antibodies in severe progressive multiple sclerosisEUCTR2008-002626-11-SEDept of Neurology
进行中（未招募）
1 期
Efficacy and safety of thalidomide in pediatric patients with Crohn's diseaseCrohn's DiseaseEUCTR2016-000786-24-ITIRCCS Burlo Garofolo124
招募中
不适用
Study for development of new treatment for antibody mediated rejection in organ transplantatioorgan failureJPRN-UMIN000030525Tokyo Women's Medical University41